Nous factors implicats en la patologia cardíaca i l’obesitat

dc.contributor
Universitat de Barcelona. Departament de Bioquímica i Biomedicina Molecular
dc.contributor.author
Ferrer Curriu, Gemma
dc.date.accessioned
2021-11-25T09:45:46Z
dc.date.available
2021-11-25T09:45:46Z
dc.date.issued
2020-07-23
dc.identifier.uri
http://hdl.handle.net/10803/672828
dc.description
Programa de Doctorat en Biomedicina
en_US
dc.description.abstract
Cardiovascular diseases are one of the leading causes of mortality in industrialized countries and are caused by genetic factors, environmental factors or comorbidities. This thesis is focused on three cardiovascular risk factors such as hypertension, alcoholism and obesity. These pathologies are mainly characterized by hypertrophy and cardiac fibrosis. In recent last years, cardiomyokines have been described as cardioprotective factors against pathological stimuli. One of the most important cardiomyokines is Fibroblast growth factor 21 (FGF21). FGF21 is released by the heart under cardiac stress situations where acts in a autocrine or paracrine manner protecting cardiomyocytes against inflammation, oxidative stress and apoptosis. FGF21 has been described as a protective factor against cardiac hypertrophy, atherosclerosis, ischemia and other cardiac pathologies. In the first part this thesis has studied the role of FGF21 in hypertensive and alcoholic cardiomyopathy. It has been identified that FGF21 gene expression in heart and its circulating levels are induced in response to hypertension, and that FGF21 acts at cardiac level protecting against cardiac fibrosis. Its protective effect has been confirmed in newborn animals treated with FGF21 where cardiac fibrosis was reversed. Moreover, this protective effect on cardiac fibrosis is due to a direct effect of FGF21 on cardiac fibroblasts. It has also been identified that FGF21 gene expression in heart and its circulating levels are induced in response to chronic alcohol consumption. In contrast, lack of FGF21 altered cardiac metabolism, oxidative stress and mitochondrial damage in animals subjected to chronic alcohol consumption. In addition, a positive correlation between myocardial FGF21 levels and oxidative stress have been found in alcoholic patients suggesting a role of FGF21 in the activation of antioxidant defenses during alcoholic cardiomyopathy. On the other hand, this thesis has avaluated two proteins involved in the regulation of energy expenditure through brown adipose tissue (BAT). BAT is the main energy-consuming tissue in mammals. It is considered that BAT may play a role in protecting against obesity. Metrnl is a metabolic regulator that promotes TAM activation while Oncostatin M (OSM) inhibits it. In the last part of this thesis we have studied the role of Metrnl and OSM in obese patients undergoing bariatric surgery. Metrnl circulating levels increase progressively after bariatric surgery while OSM levels decrease in obesity patients undergoing bariatric surgery. This suggests that bariatric surgery modulates circulating levels of these two proteins in an opposite manner in order to activate BAT and promote energy expenditure in these obese patients. In summary, FGF21 appears to play an important role in the protection of cardíac fibrosis induced by hypertensive cardiomyopathy. In addition, FGF21 also appears to play an important role in activating antioxidant defenses during alcoholic cardiomyopathy. Lastly, Metrnl and OSM could be regulated during bariatric surgery to promote energy expenditure activation and protect against obesity.
en_US
dc.format.extent
218 p.
en_US
dc.format.mimetype
application/pdf
dc.language.iso
cat
en_US
dc.publisher
Universitat de Barcelona
dc.rights.license
L'accés als continguts d'aquesta tesi queda condicionat a l'acceptació de les condicions d'ús establertes per la següent llicència Creative Commons: http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.uri
http://creativecommons.org/licenses/by-nc-nd/4.0/
*
dc.source
TDX (Tesis Doctorals en Xarxa)
dc.subject
Hipertensió
en_US
dc.subject
Hipertensión
en_US
dc.subject
Hypertension
en_US
dc.subject
Malalties del cor
en_US
dc.subject
Enfermedades del corazón
en_US
dc.subject
Heart diseases
en_US
dc.subject
Consum d'alcohol
en_US
dc.subject
Consumo de alcohol
en_US
dc.subject
Drinking of alcoholic beverages
en_US
dc.subject
Cirurgia de l'obesitat
en_US
dc.subject
Cirugía de la obesidad
en_US
dc.subject
Obesity surgery
en_US
dc.subject.other
Ciències de la Salut
en_US
dc.title
Nous factors implicats en la patologia cardíaca i l’obesitat
en_US
dc.type
info:eu-repo/semantics/doctoralThesis
dc.type
info:eu-repo/semantics/publishedVersion
dc.subject.udc
577
en_US
dc.contributor.director
Planavila Porta, Ana
dc.contributor.director
Villarroya i Gombau, Francesc
dc.contributor.tutor
Villarroya i Gombau, Francesc
dc.embargo.terms
cap
en_US
dc.rights.accessLevel
info:eu-repo/semantics/openAccess


Documents

GFC_TESI.pdf

13.40Mb PDF

This item appears in the following Collection(s)